We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+30.6%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$43.1B
AUM Growth
+$3.9B
Cap. Flow
+$196M
Cap. Flow %
0.46%
Top 10 Hldgs %
17.24%
Holding
3,508
New
269
Increased
1,735
Reduced
1,181
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 9.57%
2 Healthcare 9.13%
3 Financials 8.63%
4 Industrials 6.92%
5 Communication Services 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GUT
2851
Gabelli Utility Trust
GUT
$559M
$223K ﹤0.01%
33,880
+11,007
+48% +$70.6K
MNTA
2852
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$223K ﹤0.01%
16,720
+694
+4% +$10.9K
BAS
2853
DELISTED
Basis Energy Services, Inc.
BAS
$223K ﹤0.01%
+6,698
New +$252K
FRME icon
2854
First Merchants
FRME
$2.67B
$222K ﹤0.01%
+5,653
New +$220K
NEOG icon
2855
Neogen
NEOG
$2.5B
$222K ﹤0.01%
+9,027
New +$221K
PMT
2856
PennyMac Mortgage Investment
PMT
$842M
$222K ﹤0.01%
12,490
-4,105
-25% -$69.6K
P
2857
Everpure Inc
P
$29.9B
$222K ﹤0.01%
22,600
-71,379
-76% -$791K
BLUE
2858
DELISTED
bluebird bio
BLUE
$221K ﹤0.01%
+188
New +$192K
ETN icon
2859
CALL
Eaton
ETN
$174B
$221K ﹤0.01%
86,400
+7,300
+9% +$519K
AGGE
2860
DELISTED
IQ Enhanced Core Bond U.S. ETF
AGGE
$221K ﹤0.01%
11,393
+428
+4% +$8.32K
RTH icon
2861
VanEck Retail ETF
RTH
$263M
$220K ﹤0.01%
2,789
-240
-8% -$18.7K
SCHE icon
2862
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$220K ﹤0.01%
+9,195
New +$214K
ICPT
2863
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$220K ﹤0.01%
+1,949
New +$228K
ILG
2864
DELISTED
ILG, Inc Common Stock
ILG
$220K ﹤0.01%
10,509
+153
+1% +$2.88K
DKL icon
2865
Delek Logistics
DKL
$3.02B
$219K ﹤0.01%
+6,565
New +$212K
ANGL icon
2866
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.06B
$218K ﹤0.01%
+7,361
New +$215K
JOE icon
2867
St. Joe Company
JOE
$3.83B
$218K ﹤0.01%
+12,795
New +$219K
BOJA
2868
DELISTED
Bojangles', Inc. Common Stock
BOJA
$218K ﹤0.01%
+10,625
New +$212K
BUI icon
2869
BlackRock Utilities, Infrastructure & Power Opportunities Trust
BUI
$715M
$217K ﹤0.01%
10,946
-9,354
-46% -$182K
HUBG icon
2870
HUB Group
HUBG
$2.92B
$217K ﹤0.01%
9,350
-100
-1% -$2.36K
SFBS
2871
ServisFirst Bancshares
SFBS
$4.86B
$217K ﹤0.01%
5,976
+490
+9% +$19.2K
SRPT icon
2872
Sarepta Therapeutics
SRPT
$1.77B
$217K ﹤0.01%
7,318
-2,861
-28% -$88.5K
UUU icon
2873
Universal Safety Products Inc
UUU
$10.6M
$217K ﹤0.01%
73,513
MSF
2874
DELISTED
Morgan Stanley Emerging Mkts Fd
MSF
$217K ﹤0.01%
14,712
+3,950
+37% +$55.8K
GOV
2875
DELISTED
Government Properties Income Trust
GOV
$216K ﹤0.01%
+10,338
New +$206K

Similar funds

Raymond James & Associates's Q1 2017 Portfolio in Review

As of Q1 2017, Raymond James & Associates held 3,508 positions worth $43.1B, up 10% from $39.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Raymond James & Associates's Q1 2017 filing shows 269 new, 1,735 increased, 1,181 reduced and 217 closed positions. Its largest new stake was iShares Global REIT ETF: 2,916,742 shares worth $73.9M. The largest sale was TotalEnergies, an estimated $1.85B.

By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q1 2017 buy was iShares Global REIT ETF: 2,916,742 shares worth $73.9M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2017, an estimated $997M increase.
  • Raymond James & Associates's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $1.85B.
  • Raymond James & Associates fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $23.6M.
  • Raymond James & Associates's ten largest holdings make up 17% of its $43.1B portfolio in Q1 2017.
  • Raymond James & Associates opened 269 new positions and closed 217 in Q1 2017.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $43.1B.

Based on Raymond James & Associates's 13F filing for Q1 2017, filed 15 May 2017.